Healthcare provider profile · identity verified

James M Lacroix, MD

Family Practice · LEBANON, OH · NPI 1548239759

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	245	79
Levothyroxine Sodium	Levothyroxine Sodium	185	51
Gabapentin	Gabapentin	172	48
Citalopram Hbr	Citalopram Hydrobromide	154	42
Amlodipine Besylate	Amlodipine Besylate	152	40
Lisinopril	Lisinopril	151	43
Glipizide Er	Glipizide	142	39
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	126	16
Trazodone Hcl	Trazodone Hcl	124	37
Omeprazole	Omeprazole	110	29
Metformin Hcl Er	Metformin Hcl	103	34
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	97	23
Tamsulosin Hcl	Tamsulosin Hcl	94	29
Furosemide	Furosemide	93	26
Prednisone	Prednisone	93	59
Meloxicam	Meloxicam	91	36
Albuterol Sulfate Hfa	Albuterol Sulfate	87	31
Simvastatin	Simvastatin	80	22
Metoprolol Succinate	Metoprolol Succinate	67	21
Azithromycin	Azithromycin	61	51
Pantoprazole Sodium	Pantoprazole Sodium	61	21
Zolpidem Tartrate	Zolpidem Tartrate	58	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	57	21
Losartan Potassium	Losartan Potassium	57	18
Alprazolam	Alprazolam	55	suppressed
Duloxetine Hcl	Duloxetine Hcl	54	suppressed
Buspirone Hcl	Buspirone Hcl	49	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	49	11
Diclofenac Sodium	Diclofenac Sodium	48	25
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	48	suppressed
Tramadol Hcl	Tramadol Hcl	47	suppressed
Bupropion Hcl Sr	Bupropion Hcl	45	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	45	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	43	11
Metformin Hcl	Metformin Hcl	43	16
Bupropion Xl	Bupropion Hcl	39	suppressed
Fenofibrate	Fenofibrate	39	12
Methocarbamol	Methocarbamol	38	11
Quetiapine Fumarate	Quetiapine Fumarate	38	suppressed
Sertraline Hcl	Sertraline Hcl	38	12
Allopurinol	Allopurinol	37	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	36	12
Lovastatin	Lovastatin	33	suppressed
Lorazepam	Lorazepam	32	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	31	11
Atenolol	Atenolol	30	suppressed
Potassium Chloride	Potassium Chloride	29	11
Xarelto	Rivaroxaban	29	suppressed
Celecoxib	Celecoxib	26	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	26	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	24	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	23	20
Propranolol Hcl Er	Propranolol Hcl	23	suppressed
Pravastatin Sodium	Pravastatin Sodium	22	suppressed
Clonidine Hcl	Clonidine Hcl	20	suppressed
Donepezil Hcl	Donepezil Hcl	20	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	20	suppressed
Montelukast Sodium	Montelukast Sodium	20	suppressed
Promethazine Hcl	Promethazine Hcl	20	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	20	suppressed
Clopidogrel	Clopidogrel Bisulfate	19	suppressed
Lubiprostone	Lubiprostone	18	suppressed
Temazepam	Temazepam	18	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	17	suppressed
Eliquis	Apixaban	17	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Pregabalin	Pregabalin	17	suppressed
Clonazepam	Clonazepam	15	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	14	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	11
Ibuprofen	Ibuprofen	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	13	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Warfarin Sodium	Warfarin Sodium	12	suppressed
Carvedilol	Carvedilol	11	suppressed
Gemfibrozil	Gemfibrozil	11	suppressed
Glimepiride	Glimepiride	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Ramipril	Ramipril	11	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error